Katey Owen, PhD
Dr. Katey Einterz Owen joined the Adaptive Biotechnologies board in 2021. She is the Director for Neglected Tropical Diseases at The Bill & Melinda Gates Foundation and has responsibility for the Gates Foundation / Pharmaceutical Industry CEO Roundtable. Katey has end-to-end decision-making responsibility for the Gates Foundation’s investment portfolio in controlling, eliminating, and eradicating the diseases of the London Declaration, diseases that collectively put at risk more than one billion people in the world. Focusing on broader health work, Katey also facilitates collective interactions with the CEOs of 16 key multinational pharmaceutical organizations, resulting in joint work in global health that can most effectively be accomplished by the organizations together. Dr. Owen is active on the boards of The End Fund to end neglected diseases and GHIT, the Global Health Innovative Technology Fund. She joined BMGF in 2013 from Merck & Co, where she held senior roles in product development, manufacturing, and the commercial business over her tenure.
Prior to industry, Katey carried out academic research at the National Institute for Medical Research in London. She earned her PhD in molecular virology and her BS in genetics from Purdue University. Katey’s greatest happiness is spending time with her family and especially watching her children blossom into productive, active, and joyful adults. You can regularly find her running the trails of Bainbridge Island, WA.